Effect of Aerobic Exercise on Side Effects of Disease Modifying Therapy With Subcutaneous Interferon-b1b in Patients With Multiple Sclerosis
- Conditions
- Multiple Sclerosis
- Registration Number
- NCT01122056
- Lead Sponsor
- University of British Columbia
- Brief Summary
The purpose of this study is to investigate the effects and tolerability of exercise on side effects of injectable disease modifying treatments in multiple sclerosis. The investigators main hypothesis is that controlled exercise is safe and can be well tolerated in patients with multiple sclerosis and it can improve disease modifying treatment related side effects such as fatigue.
- Detailed Description
Patient compliance with disease modifying treatment largely depends on relatively common side effects of such treatments such as fatigue. Regular exercise can potentially improve these side effects. However, Safety and effects of exercise has not been studied in patients with multiple sclerosis. Our main aim is to study the safety, tolerability and effects of exercise on side effects of subcutaneous interferon-b1b in patients with Multiple Sclerosis.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 128
- Recent diagnosis of relapsing remitting multiple sclerosis on treatment with b1b-interferon disease modifying treatment
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Multiple Sclerosis Fatigue Injection site visual analog scale (0-10) Quality of Life
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Vancouver Coastal Health: University of British Columbia Hospital
🇨🇦Vancouver, British Columbia, Canada
Vancouver Coastal Health: University of British Columbia Hospital🇨🇦Vancouver, British Columbia, Canada